Private Wealth Management Group, LLC Avidity Biosciences, Inc. Transaction History
Private Wealth Management Group, LLC
- $253 Billion
- Q3 2024
A detailed history of Private Wealth Management Group, LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Private Wealth Management Group, LLC holds 78 shares of RNA stock, worth $2,445. This represents 0.0% of its overall portfolio holdings.
Number of Shares
78
Previous 78
-0.0%
Holding current value
$2,445
Previous $3.19 Million
12.43%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RNA
# of Institutions
255Shares Held
107MCall Options Held
224KPut Options Held
161K-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$333 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$289 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$270 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.13MShares$255 Million5.95% of portfolio
-
Wellington Management Group LLP Boston, MA7.03MShares$220 Million0.06% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.63B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...